India  

COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate

IndiaTimes Monday, 3 August 2020
Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee on -19.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR 02:24

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites. Earlier, the Drugs Controller General of...

You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Parliament's Monsoon Session likely to be cut short early as more legislators test positive for COVID-19

Amid a surge in Covid-19 cases in the country, all political parties in a Business Advisory Committee (BAC) of Parliament on Saturday agreed to curtail the..
DNA
Protesters clash with police at anti-vaccine rally in London [Video]

Protesters clash with police at anti-vaccine rally in London

Hundreds from a group calling themselves 'Resist and Act' have gathered in central London to rally against Covid-19 vaccines and public health restrictions. Scuffles broke out between protesters and police, after the crowds formed human blockades opposite the officers to stop them from making arrests. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:58Published
IPL 2020: Delhi Capitals preparations changed this season due to COVID, says Head Coach [Video]

IPL 2020: Delhi Capitals preparations changed this season due to COVID, says Head Coach

Ahead of their season's opening match against Kings XI Punjab, the head coach of Delhi Capitals Ricky Ponting on September 19 said that IPL 2020 is going to be very different due to COVID-19 pandemic, and so will the preparations of Delhi Capitals. "Certainly it's going to be different, our preparations for playing this IPL is going to be different in anyway. The boys and the whole squad here have been under very strict COVID protocols which is unusual and different. So once we get to play our first game, playing in every stadium will be different there will some challenges there for the boys, but I do think that once the game starts I think we will get support from all around India and certainly in Delhi for the capitals," said Ponting ahead of their first match against Kings XI Punjab.

Credit: ANI    Duration: 01:26Published
Rochester Mass Shooting: Two Killed at Illegal Party [Video]

Rochester Mass Shooting: Two Killed at Illegal Party

Two people have been killed and 14 have been left injured after a mass shooting in Rochester, New York state.   The attack happened at a gathering of about 100 people, which police said was breaking Covid-19 restrictions.   Interim Police Chief Mark Simmons added none of those wounded are believed to have sustained life-threatening injuries.    This comes after Rochester Police Department was rocked by the suffocation death of Daniel Prude. Report by Avagninag. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:53Published
Infantino says COVID relief money will go where needed, condemns racism as a 'virus' in soccer [Video]

Infantino says COVID relief money will go where needed, condemns racism as a 'virus' in soccer

FIFA President Gianni Infantino says the one and a half billion pounds earmarked to help soccer get over the coronavirus pandemic will be used wisely.

Credit: Reuters - Sports    Duration: 04:41Published

Drugs Controller General of India

Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the..
DNA

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19..
IndiaTimes

Serum Institute of India to resume clinical trials of AstraZeneca-Oxford's COVID-19 vaccine after DGCI nod

The Pune-based Serum Institute of India (SII) is all set to resume the clinical trials of AstraZeneca-Oxford's COVID-19 vaccine candidate AZD1222 after receiving..
DNA

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.

Credit: HT Digital Content    Duration: 01:19Published
Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning [Video]

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning

From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:18Published

Oxford Oxford City and non-metropolitan district in England

Boris Johnson visits vaccine research lab [Video]

Boris Johnson visits vaccine research lab

Prime Minister Boris Johnson has visited a laboratory at the Jenner Institute in Oxford which is leading the research into a vaccine for Covid-19. Report by Etemadil. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 03:31Published
UK will get first access to Oxford vaccine, No 10 says [Video]

UK will get first access to Oxford vaccine, No 10 says

The UK would be first in line for a coronavirus vaccine developed by OxfordUniversity if it was proven to be effective, Downing Street has said. It comesafter reports Donald Trump is considering granting emergency authorisation forit to be deployed in the US.

Credit: PA - Press Association STUDIO    Duration: 02:20Published
Mexico signs COVID-19 vaccine deal as cases top 500,000 [Video]

Mexico signs COVID-19 vaccine deal as cases top 500,000

The agreement reached with Argentina covers initial production of 150 million doses of vaccine developed by Oxford.

Credit: Al Jazeera STUDIO    Duration: 01:58Published

Related videos from verified sources

Coronavirus vaccine trials still struggling for diversity [Video]

Coronavirus vaccine trials still struggling for diversity

Right now, nine COVID-19 vaccines are in or near a large-scale human trial phase. But enrollment of minorities in the trials remains a challenge.

Credit: NBC 26 Wisconsin     Duration: 02:44Published
If all goes well, expect COVID vaccine by early next year: AIIMS doctor [Video]

If all goes well, expect COVID vaccine by early next year: AIIMS doctor

As clinical trials of different COVID-19 vaccines are in various phases across the globe, an AIIMS (All India Institute of Medical Sciences) doctor said that if everything goes as planned, people can..

Credit: ANI     Duration: 02:26Published
Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News [Video]

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's..

Credit: Oneindia     Duration: 01:03Published

Related news from verified sources

COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate

Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after...
IndiaTimes Also reported by •Indian ExpressHinduDNAZee NewsnewKerala.com

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford...
IndiaTimes Also reported by •newKerala.com

Mass production of COVID-19 vaccine to begin in India once scientists give nod, says PM Modi

Three vaccine candidates are in different stages of human clinical trials in India.
Hindu Also reported by •DNAnewKerala.com

Tweets about this